National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

methoxy polyethylene glycol epoetin beta
A pegylated form of recombinant human erythropoietin, a glycosylated protein naturally produced in the kidney that stimulates erythrocyte production in the bone marrow. Methoxypolyethylene glycol epoetin beta may reverse anemias induced by cancer therapy. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Mircera
Code name:Ro 50-3821



Previous:Methosarb, methotrexate, Methotrexate LPF, methotrexate-e therapeutic implant, methoxsalen
Next:methoxyamine, methyl-5-aminolevulinate hydrochloride cream, methylene blue, methylene dimethane sulfonate, methylmercaptopurine riboside

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov